Covidien received U.S. and E.U. approvals to bring to market its Parietex Optimized Composite (PCOx) mesh. The device is an improvement on the company’s Parietex Composite (PCO) mesh used in open and laparoscopic ventral hernia repair procedures. According to Covidien, “the new product design incorporates a more resistant barrier and a proprietary textile design with better visibility and increased strength.”
Features from the product page:
- Parietex™ Composite dual-sided mesh provides optimal tissue in-growth and fewer visceral attachments
- The skirt on parietal side provides accessible, secure fixation points
- Increased rigidity during implantation allows superior handling
- The polyester material softens and conforms to the anatomy once implanted
- Protects viscera from fixation points
- Available in three sizes to meet a wide range of clinical needs
Product page: Parietex™ Composite: Polyester Mesh Resorbable Film …
Press release: Covidien Announces U.S. 510(k) Clearance and European CE Mark Approval of Parietex™ Optimized Composite Mesh …
